Epirubicin at two dose levels with prednisolone as treatment for advanced breast cancer: The results of a randomized trial

Journal of Clinical Oncology

Volumn 9, Issue 2, 1991, Pages 295-304

  Habeshaw, T ^a   Paul, J ^a   Jones, R ^a   Stallard, S ^a   Stewart, M ^a   Kaye, S B ^a   Soukop, M ^a   Symonds, R P ^a   Reed, N S ^a   Rankin, E M ^a  

^a BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPIRUBICIN; PREDNISOLONE;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ARTICLE; BONE MARROW SUPPRESSION; BREAST CANCER; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MUCOSA INFLAMMATION; PRIORITY JOURNAL;

ADULT; AGED; ALOPECIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; DRUG ADMINISTRATION SCHEDULE; EPIRUBICIN; FEMALE; FOLLOW-UP STUDIES; HUMAN; MIDDLE AGE; PREDNISOLONE; SURVIVAL RATE; TASTE DISORDERS; THROMBOPHLEBITIS;

EID: 0026032603     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1991.9.2.295     Document Type: Article

References (30)

1. Powles TJ, Coombes RC, Smith IE, et al: Failure of chemotherapy to prolong survival in a group of patients with metastatic breast cancer. Lancet 1:580-582, 1980
2. Brambilla C, Rossi A, Bonfante V, et al: Phase II study of doxorubicin versus epirubicin in advanced breast cancer. Cancer Treat Rep 70:261-266, 1986
3. French epirubicin study group: A prospective randomized phase III trial comparing combination chemotherapy with cyclophosphamide, fluorouracil, and either doxorubicin or epirubicin. J Clin Oncol 6:679-688, 1988
4. Steiner R, Stewart JF, Cantwell BMJ, et al: Adriamycin alone or combined with vincristine in the treatment of advanced breast cancer. Eur J Cancer Clin Oncol 19:1553-1557, 1983
5. Minton MJ, Knight RK, Rubens RD, et al: Corticosteroids for elderly patients with breast cancer. Cancer 48:883-887, 1981
6. Carmo-Pereira J, Costa FO, Henriques E, et al: Advanced breast carcinoma: A comparison of two dose levels of Adriamycin. Proc Ann Meet Am Soc Clin Oncol 5:56, 1986 (abstr)
7. Baum M, Priestman T, West RR, et al: A comparison of subjective responses in a trial comparing endocrine with cytotoxic treatment in advanced carcinoma of the breast, in Mouridsen HT and Palshof T (ed): Breast Cancer. Experience and Clinical Aspects. London, England, Pergamon Press, 1979 pp 223-226
8. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomised clinical trials requiring prolonged observation of each patient 1. Introduction and design. Br J Cancer 34:585-612, 1976
9. Bartolucci AA: Estimation and Comparison of Proportions, in Buyse ME, Staquet MJ, Sylvester RJ (eds): Cancer Clinical Trials - Method and Practice. New York, NY, Oxford, 1985, pp 337-360
10. Armitage P, Berry G: Statistical Methods in Medical Research (ed 2). New York, NY, Blackwell Scientific Publications, 1987, pp 382-383
11. Pocock SJ: Clinical Trials-A Practical Approach. New York, NY, Wiley, 1983
12. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35:1-39, 1977
13. Cox DR, Oakes D: The Analysis of Survival Data. New York, NY, Chapman and Hall, 1984
14. Molina R, Slavik M, Chien SC, et al: Salivary excretion of Adriamycin and its metabolites. Proc Am Assoc Cancer Res Vol. 26:615, 1985 (abstr)
15. Bonnadonna G, Valagussa P: Chemotherapy of breast cancer: Current views and results. Radiat Oncol Biol Phys 9:279-297, 1983
16. Bumma C, Dogliotti E, Ciambellotti M, et al: 5-Fluorouracil, epirubicin, cyclophosphamide (FEC) vs. epirubicin in advanced breast cancer. European Conference on Clinical Oncology 5 Book of Abstracts: P-1011 September 1989 (abstr)
17. Powles TJ, Ashley SE, Forgeson GV, et al: Treatment of advanced breast cancer with mitomycin-C, mitoxantrone and methotrexate (3M) compared to vincristine, anthracycline and cyclophosphamide (VAC). Clinical progress with mitoxantrone, in G Bonnadonna (ed): Royal Society of Medicine Services International Congress and Symposium Series No. 110. London, England, Royal Society of Medicine Services Limited, 1987
18. Harris AL, Cantwell BMJ, Carmichael J, et al: Comparison of short-term and continuous chemotherapy (mitozantrone) for advanced breast cancer. Lancet 335:186-190, 1990
19. Ahmann DL, Schaid DJ, Bisel HF, et al: The effect of initial chemotherapy in advanced breast cancer: Polychemotherapy versus single drug. J Clin Oncol 5:1928-1933, 1987
20. Canellos GP, Pocock SJ, Taylor SG, et al: Combination chemotherapy for metastatic breast carcinoma. Cancer 38:1882-1886, 1976
21. Leonard RC, Cornbleet MA, Kaye SB, et al: Mitoxantrone versus doxorubicin in combination chemotherapy for advanced carcinoma of the breast. J Clin Oncol 6:1056-1063, 1987
22. Coates A, Gerbski V, Bishop JF, et al: Improving the quality of life during chemotherapy for advanced breast cancer. N Engl J Med 317:1490-1495, 1987
23. Gambrosier P, Tabiadon D, Vinci M, et al: Evaluation of new CMF regimes in advanced breast cancer (ABC). Proc Eur Conf Clin Oncol 4:438, 1987 (abstr)
24. Ross MB, Buzdar AU, Smith TL, et al: Improved survival of patients with metastatic breast cancer receiving chemotherapy. Cancer 55:341-346, 1985
25. Patel JK, Nemoto T, Vezeridis M, et al: Does more intensive palliative treatment improve overall survival in metastatic breast cancer patients? Cancer 57:567-570, 1986
26. A'Hern RP, Ebbs SR, Baum MB: Does chemotherapy improve survival in advanced breast cancer? A statistical overview. Br J Cancer 57:615-618, 1988
27. Rosner D, Nemoto T, Lane WW: A randomised study of intensive versus moderate chemotherapy programs in metastatic breast cancer. Cancer 59:874-883, 1987
28. Hortobagyi GN, Bodey GP, Buzdar AU, et al: Evaluation of high-dose versus standard FAC chemotherapy for advanced breast cancer in protected environment units: A prospective randomized study. J Clin Oncol 5:354-364, 1987
29. Jones RD, Kerr DJ, Harnett AN, et al: A pilot study of quinidine and epirubicin in the treatment of advanced breast cancer. Br J Cancer 62:133-135, 1990
30. Keith WN, Stallard S, Brown R: Expression of mdr 1 and gst-pi in human breast tumours: Comparison to in vitro chemosensitivity. Br J Cancer 61:712-716, 1990